featured
The Impact of Dupilumab on Patch Testing and the Prevalence of Co-Morbid ACD in Recalcitrant Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Impact of Dupilumab on Patch Testing and the Prevalence of Co-Morbid ACD in Recalcitrant Atopic Dermatitis: A Retrospective Chart Review
J Am Acad Dermatol 2019 Sep 25;[EPub Ahead of Print], J Raffi, R Suresh, N Botto, JE MuraseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.